Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001214659-24-004795 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-19 | 2024-03-15 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | S - Sale | $6.00 | -50.0K | 984.5K | -5% | -$300.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | S | D | 50,000 | $6.00 | 984,476 | D | — | — |